The Hungarian pharmaceutical company Gedeon Richter Plc. presented its results for the year 2022 this Tuesday. The report caused a price drop on the stock market, as it turned out that the always massively profitable company turned loss-making in the last quarter of the year (due to the special tax and the exchange rate change). […]
Gedeon Richter Plc. and Mithra Pharmaceuticals have announced that they signed a license agreement for the commercialisation of Donesta®, a novel product candidate for the treatment of post-menopausal symptoms, according to a statement on the website of the Budapest Stock Exchange. The completion of the agreement follows the signing of the Binding Term Sheet by […]
The Hungarian pharmaceutical company Gedeon Richter Plc. has announced on the website of the Budapest Stock Exchange that it has acquired from shareholders of Consilient Health 100% control of OC Distributors Ltd., an Ireland based company holding the marketing and distribution rights of a number of women’s healthcare products. The transaction value is GBP 32.5 […]
The University of Pécs (PTE) and the pharma firm Gedeon Richter Plc. (Richter) are creating an infrastructure and professional knowledge base worth more than HUF five billion in cooperation, which can be used in the fields of pharmaceutical research and agricultural science, among others, and is also suitable for the structural analysis of macromolecules, the […]
The Hungarian pharmaceutical giant Gedeon Richter Plc. has published an extraordinary announcement on the website of the Budapest Stock Exchange that under a new government decree on the extra profit taxes, the magnitude of supplementary pharmaceutical tax payable by the company for the year 2022 is expected to be approximately HUF 28 billion. “On June […]
The Hungarian pharma company Gedon Richter’s partner AbbVie has announced that the U.S. Food and Drug Administration (FDA) has approved VRAYLAR® (cariprazine) as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults. Supported by clinical data demonstrating efficacy and well-established tolerability, this additional indication provides a new option for […]
The Hungarian pharmaceutical firm Gedeon Richter Plc. has announced an important change in the executive management of company on the website of the Budapest Stock Exchange. “The company hereby informs its honorable shareholders that with effect from November 15, 2022 Mr. Erik Bogsch resigns from his position regarding the direct supervision of Commercial, International and […]
Richter Gedeon Plc. has built and equipped a new molecular biology laboratory at its Debrecen site. The investment was part of a multi-year, partly EU-funded, HUF 4.83 billion research and development (R&D) project to support biotechnology drug development, the Budapest-listed pharmaceutical company told the state news agency MTI on Monday. According to the statement, the […]
Hungarian phrama company Gedeon Richter Plc. has announced that it has submitted a Type II Variation application for RYEQO® to the European Medicines Agency (EMA) for the treatment of moderate to severe pain associated with endometriosis in adult women of reproductive age with a history of previous medical or surgical treatment for their endometriosis. RYEQO® […]
